GPCR logo

Structure Therapeutics Inc. (GPCR) Cash From Operations

Annual CFO:

-$116.64M-$37.15M(-46.73%)
December 31, 2024

Summary

  • As of today, GPCR annual cash from operations is -$116.64 million, with the most recent change of -$37.15 million (-46.73%) on December 31, 2024.
  • During the last 3 years, GPCR annual cash from operations has fallen by -$84.48 million (-262.67%).
  • GPCR annual cash from operations is now -716.61% below its all-time high of -$14.28 million, reached on December 1, 2020.

Performance

GPCR Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGPCRcash flow metrics

Quarterly CFO:

-$54.75M-$2.44M(-4.67%)
June 30, 2025

Summary

  • As of today, GPCR quarterly cash from operations is -$54.75 million, with the most recent change of -$2.44 million (-4.67%) on June 30, 2025.
  • Over the past year, GPCR quarterly cash from operations has dropped by -$28.38 million (-107.63%).
  • GPCR quarterly cash from operations is now -450.62% below its all-time high of -$9.94 million, reached on June 1, 2022.

Performance

GPCR Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGPCRcash flow metrics

TTM CFO:

-$163.35M-$28.38M(-21.03%)
June 30, 2025

Summary

  • As of today, GPCR TTM cash from operations is -$163.35 million, with the most recent change of -$28.38 million (-21.03%) on June 30, 2025.
  • Over the past year, GPCR TTM cash from operations has dropped by -$60.33 million (-58.56%).
  • GPCR TTM cash from operations is now -1113.39% below its all-time high of -$13.46 million, reached on March 1, 2022.

Performance

GPCR TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGPCRcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

GPCR Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-46.7%-107.6%-58.6%
3Y3 Years-262.7%-450.6%-597.9%
5Y5 Years-716.6%--

GPCR Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-262.7%at low-450.6%at low-597.9%at low
5Y5-Year-716.6%at low-450.6%at low-1113.4%at low
All-TimeAll-Time-716.6%at low-450.6%at low-1113.4%at low

GPCR Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$54.75M(-4.7%)
-$163.35M(-21.0%)
Mar 2025
-
-$52.30M(-43.5%)
-$134.97M(-15.7%)
Dec 2024
-$116.64M(-46.7%)
-$36.44M(-83.4%)
-$116.69M(-14.2%)
Sep 2024
-
-$19.87M(+24.7%)
-$102.17M(+0.8%)
Jun 2024
-
-$26.37M(+22.5%)
-$103.02M(-10.5%)
Mar 2024
-
-$34.02M(-55.3%)
-$93.27M(-17.4%)
Dec 2023
-$79.49M
-$21.91M(-5.7%)
-$79.42M(-38.1%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$20.72M(-24.7%)
-$57.51M(-56.3%)
Jun 2023
-
-$16.61M(+17.7%)
-$36.79M(-22.1%)
Mar 2023
-
-$20.18M(-102.9%)
-$30.12M(-28.7%)
Dec 2022
-$46.12M(-43.4%)
-
-
Jun 2022
-
-$9.94M(+26.1%)
-$23.41M(-73.9%)
Mar 2022
-
-$13.46M
-$13.46M
Dec 2021
-$32.16M(-125.2%)
-
-
Dec 2020
-$14.28M
-
-

FAQ

  • What is Structure Therapeutics Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Structure Therapeutics Inc.?
  • What is Structure Therapeutics Inc. annual cash from operations year-on-year change?
  • What is Structure Therapeutics Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Structure Therapeutics Inc.?
  • What is Structure Therapeutics Inc. quarterly cash from operations year-on-year change?
  • What is Structure Therapeutics Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Structure Therapeutics Inc.?
  • What is Structure Therapeutics Inc. TTM cash from operations year-on-year change?

What is Structure Therapeutics Inc. annual cash from operations?

The current annual cash from operations of GPCR is -$116.64M

What is the all-time high annual cash from operations for Structure Therapeutics Inc.?

Structure Therapeutics Inc. all-time high annual cash from operations is -$14.28M

What is Structure Therapeutics Inc. annual cash from operations year-on-year change?

Over the past year, GPCR annual cash from operations has changed by -$37.15M (-46.73%)

What is Structure Therapeutics Inc. quarterly cash from operations?

The current quarterly cash from operations of GPCR is -$54.75M

What is the all-time high quarterly cash from operations for Structure Therapeutics Inc.?

Structure Therapeutics Inc. all-time high quarterly cash from operations is -$9.94M

What is Structure Therapeutics Inc. quarterly cash from operations year-on-year change?

Over the past year, GPCR quarterly cash from operations has changed by -$28.38M (-107.63%)

What is Structure Therapeutics Inc. TTM cash from operations?

The current TTM cash from operations of GPCR is -$163.35M

What is the all-time high TTM cash from operations for Structure Therapeutics Inc.?

Structure Therapeutics Inc. all-time high TTM cash from operations is -$13.46M

What is Structure Therapeutics Inc. TTM cash from operations year-on-year change?

Over the past year, GPCR TTM cash from operations has changed by -$60.33M (-58.56%)
On this page